Group 1 - The local market supervision administration held a meeting with the heads of 9 retail pharmaceutical companies to discuss the standardization of drug and medical device management [1][3] - Key provisions of the Drug Administration Law and Drug Quality Management Standards were explained, focusing on issues that may arise during the procurement, acceptance, storage, maintenance, and sales of drugs and medical devices [3] - Companies were required to immediately rectify any identified issues and enhance employee training while improving operational systems [3] Group 2 - The administration plans to implement a combination of daily inspections, special checks, and unannounced inspections to monitor compliance in drug and medical device operations [3] - Strict legal actions will be taken against any violations discovered during these inspections [3]